Eighty AHA patients were retrospectively analysed by assessing FVIII inhibitor levels, antibody isotypes (IgG, IgA, IgM), IgG subclasses, and domain specificity using a bead‐based assay. Here, CD79A is linked to autoimmune hemolytic anemia.